We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Allergan to Acquire Vitae for $639M

News   Sep 16, 2016

 
Allergan to Acquire Vitae for $639M
 
 
 

RELATED ARTICLES

Bioactive Agents Improve Synthetic Bone Substitutes

News

Synthetic bone substitutes are promising materials for bone defect repair, but their efficacy can be substantially improved by bioactive agents such as growth factors. In a new study, researchers have modified beta-tricalcium phosphate (β-TCP) with increasing quantities of bone morphogenetic protein 2 (BMP-2) derived from E. coli and shown improved bone healing.

READ MORE

Developing Pioneering Cell Therapies for Immunotherapy Non-responders

News

New research signposts a novel, less invasive method to identify killer T lymphocytes in patients with gastrointestinal tumors with low mutational burden who are refractory to currently-approved immune-based treatments.

READ MORE

Changes Associated With Alzheimer's Disease Detectable in Blood Samples

News

Researchers have discovered new changes in blood samples which are associated with Alzheimer’s disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE